Health Insurance Bureau: Drugstores can only increase the price of 15% of the drug sales and up to 200 yuan

The Health Insurance Bureau issued a letter, fixed-point retail pharmacies sales collection platform drugs, can only increase the price of 15%, and the maximum can only increase the price of 200 yuan(Note: The collection platform medicine slyly mentioned here refers to the medical insurance catalog of drugs included in the online transaction of the Pharmaceutical Procurement Platform in Zhejiang Province)the Medical Insurance Bureau issued a letter, pharmacies can only increase the price by 15%
On January 8, the Zhejiang Provincial Health Insurance Bureau issued the "Promoting the centralized procurement function of drugs to promote the full coverage of medical insurance drug payment standards reform program (draft for comments)" (hereinafter referred to as the "Programme")the Programme put forward specific measures on the standards for the centralized procurement of medicines and the payment of medical insurance drugsThe scope of implementation involves all public medical institutions in the province, medical insurance fixed-point private medical institutions and medical insurance fixed-point retail pharmacies, the Program for retail pharmacies medical insurance drug payment standards clearly stated that all fixed-point retail pharmacies in the province to implement a unified standard of medical insurance drug payment standards, in the established medical institutions on the basis of the payment standards up to 15% (excluding national and provincial negotiated drugs), up to 200 yuan (in minimum packaging)in accordance with the Program, because medical institutions (including private medical institutions) unified implementation of the policy of zero-plus drugs, the implementation of a unified medical insurance drug payment standards, which also means that fixed-point retail pharmacies sales collection platform drugs, can only increase the price of 15%, and the maximum can only increase the price of 200 yuansales collection of drugs, can only be appropriately increasedin fact, for this Zhejiang Province requires retail pharmacies can only increase the price of 15% of sales collection platform drugs, in the author's view, is not surprisingas early as October 24 last year, Zhejiang Provincial Health Insurance Bureau issued the "Zhejiang Province basic medical insurance fixed-point pharmacy management interim measures (draft for comments)" clearly pointed out that the fixed-point pharmacy drug sales price in accordance with the public hospital medical insurance payment standards on the basis of the appropriate increase, plus a proportion of separate provisionsalso, the price increase mentioned here 15% is not the first case, earlier in Taicang City, Jiangsu Province issued the relevant documents also talked about the medical insurance catalog centralized bidding procurement of Western medicine, Traditional Chinese medicine to implement price-limiting management, with a winning bid plus 15% for the medical insurance to pay the price limitaccording to the requirements of the National Medical Insurance Administration, medical insurance fixed-point retail pharmacies to participate in the procurement, may allow them to be appropriate lying on the basis of the selected price, the part exceeding the payment standard is paid by the patient, the following part of the payment standard by the medical insurance reimbursement according to the provisionson the summary, this time Zhejiang Province again sent a letter about the increase of 15%, the impact or is no longer Zhejiang Province, but the national fixed-point retail pharmaciesmore than 50% of the varieties, to be limitedin addition, according to the "Zhejiang Province basic medical insurance fixed-point pharmacy management interim measures (draft for comments)" (hereinafter referred to as "Measures"), pharmacies equipped with the provincial drug procurement platform online trading drug varieties not less than 50%The scope of sales of medical supplies is limited to drugs, Traditional Chinese medicine, medical equipment (with "arms" goods), disinfection supplies (with "Wei-Yi" goods) and other medical supplies, daily necessities, cosmetics, health care products, etc are not allowed to enter the fixed-point drugstore if in accordance with this requirement, that is, in the fixed-point drugstore sales of more than 50 varieties of drugs from the provincial drug procurement platform, which also means that the fixed-point drugstore more than 50 drug varieties can only increase the price of 15% also, the approach also states that the health insurance fund does not pay for the sale of drugs outside the provincial drug procurement platform by targeted pharmacies Medical insurance payment drugs must be unified procurement through the provincial drug procurement platform This further limits the scope of purchase of fixed-point retail pharmacies and the variety of medical insurance payments.